Method of treating autoimmune and/or viral-induced diseases that are mediated by CD8 phenotype T cells
US5660828A · kind A · utility
20Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 6, 1994 |
| Grant date | Aug 26, 1997 |
| Priority date | — |
| Expiry date | Jan 6, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method to block cytolytic activity of CD8 phenotype T cells using an effective amount of a complement-fixing anti CD8 antibody is described. The anti CD8 antibody may be used to treat patients with immunopathologic disorders induced by viruses or (autoimmune diseases) such as multiple sclerosis, viral or post-viral polyneuropathy, viral or post-viral myocarditis, insulitis, encephalomyelitis, myositis, synovitus, and arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.